Improving patient outcomes through better use of blood products

通过更好地使用血液制品改善患者的治疗效果

• 批准号: nhmrc : 1194811
• 金额: $ 141.23万
• 依托单位国家: 澳大利亚
• 项目类别: Investigator Grants
• 财政年份: 2021
• 资助国家: 澳大利亚
• 起止时间: 2021-01-01 至 2025-12-31
• 项目状态: 未结题
• 来源: https://researchdata.edu.au/improving-patient-outcomes-blood-products/1778895
• 关键词: Improving; patient; outcomes; through; better

Blood transfusions, used wisely, save lives. Blood must be used judiciously: it is donated by volunteers, and carries risks and great cost to the community. Although a common intervention, evidence in many areas is inadequate to formulate recommendations on how blood should be used. This research program will address national priorities where evidence is weak by undertaking clinical trials to compare transfusion strategies, evaluate alternatives to transfusion and test novel blood components.

如果使用得当，输血可以挽救生命。血液的使用必须谨慎：它是由志愿者捐献的，对社区来说有风险和巨大的成本。虽然这是一种常见的干预措施，但许多领域的证据不足以制定关于如何使用血液的建议。该研究计划将通过开展临床试验来比较输血策略、评估输血替代方案和检测新型血液成分，解决证据薄弱的国家重点问题。